# Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer

> **NCT01175733** · PHASE1,PHASE2 · COMPLETED · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 18 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Panitumumab

## Key facts

- **NCT ID:** NCT01175733
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07-08
- **Primary completion:** 2016-03
- **Final completion:** 2016-05
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01175733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01175733, "Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01175733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*